Animal and cell study links CBD-rich extract with fewer UVB tumours
Full-spectrum cannabidiol-rich extract prevents UVB-induced skin carcinogenesis by suppressing CB1/CB2/GPR55 signalling and COX-2/IL-6 inflammatory pathways.
AI Summary
The study asked whether a full-spectrum cannabidiol-rich extract (FS-CBD) could limit UVB-related skin cancer development. Researchers tested it in UVB-exposed HaCaT skin cells and CD-1 et/et mice; this was laboratory and animal research, not a human trial. In mice, UVB exposure was associated with an 80% increase in tumour incidence compared with control treatment. FS-CBD pretreatment was associated with tumour incidence of 20%, which the abstract describes as a 75% reduction. Tumour number and size also decreased by approximately 50%.
In the cell experiments, UVB increased CB1 and CB2 expression and reduced GPR55 expression; FS-CBD attenuated these changes and restored GPR55 expression. In mice, treatment was also accompanied by lower detection of these receptors and of the inflammatory markers COX-2 and IL-6. Longer pretreatment was associated with increased epidermal cell death and less frequent malignant transformation. These findings suggest possible chemopreventive effects in the tested models, but this abstract-based summary cannot establish that FS-CBD prevents skin cancer in people, or determine its safety or effectiveness in humans.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.